Genetic control of mammalian T-cell proliferation with a synthetic RNA regulatory system - illusion or reality?

Sang Kil Lee, George A. Calin

Research output: Contribution to journalComment/debate


Synthetic RNA-based regulatory systems are used to program higher-level biological functions that could be exploited, among many applications, for in vivo diagnostic and therapeutic applications. Chen and colleagues have recently reported a significant technological advance by producing an RNA modular device based on a hammerhead ribozyme and successfully tested its ability to control the proliferation of mammalian T lymphocytes. Like all exciting research, this work raises a lot of significant questions. How quickly will such knowledge be translated into clinical practice? How efficient will this system be in human clinical trials involving adaptive T-cell therapy? We discuss the possible advantages of using such new technologies for specific therapeutic applications.

Original languageEnglish
Article number77
JournalGenome Medicine
Issue number10
Publication statusPublished - 2010 Oct 15


All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Genetics(clinical)

Cite this